Metraipolis › archive › dc_7c1db784c49d
Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41026099
- DOI
- 10.1002/advs.202509309
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T15:19:19.446Z
- SHA-256 of the archived text
b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98- Stable URL of this page
https://metraipolis.com/documento/dc_7c1db784c49d
How to cite
Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099 — Europe PMC (en), https://europepmc.org/article/MED/41026099 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c1db784c49d (Metraipolis archive dc_7c1db784c49d, sha256 b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98)
BibTeX
@misc{dc7c1db784c49d,
title = {Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41026099},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c1db784c49d; sha256 b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026099. Agents can read the archived copy with the MCP tool read_document.